



TAGRISSOTM is a third generation epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI), and is available in 40mg and 80mg dosages. Provided by the UK's pharmaceutical company, AstraZeneca (HK). TAGRISSOTM is a Hong Kong Department of Health prescription drug. For enquiry, please contact your doctor or pharmacist.
TAGRISSOTM is a Hong Kong Department of Health prescription drug. For enquiry, please contact your doctor or pharmacist.
80mg | 40mg | |
---|---|---|
Drug box | ![]() |
![]() |
Blister pack | ![]() |
![]() |
Tablet | ![]() |
![]() |
Register number | HK-64835 | HK-64834 |
80mg | |
---|---|
Drug box | ![]() |
Blister pack | ![]() |
Tablet | ![]() |
Register number | HK-64835 |
40mg | |
---|---|
Drug box | ![]() |
Blister pack | ![]() |
Tablet | ![]() |
Register number | HK-64834 |
TAGRISSOTM is a Hong Kong Department of Health prescription drug. For enquiry, please contact your doctor or pharmacist.
If you are prescribed TAGRISSOTM , you can refer to the below dosing information.
TAGRISSOTM is a Hong Kong Department of Health prescription drug. For enquiry, please contact your doctor or pharmacist.
TAGRISSOTM is a Hong Kong Department of Health prescription drug. For enquiry, please contact your doctor or pharmacist.
Reference : 1. TAGRISSOTM Hong Kong prescribing information. July 2016.
TAGRISSOTM and 泰瑞沙TM are the trademarks of AstraZeneca group of companies.
![]() |
Unit 1-3, 11/F, 18 King Wah Road, North Point, Hong Kong
|
![]() |
|
![]() |
(852) 24226788
|
![]() |
|
![]() |
General Enquiry: WebEnquiry.HK@astrazeneca.com
Individual Case Safety Report: HKPatientSafety@astrazeneca.com |
Open Wechat,click the bottom「Discover」, use 「Scan QR CODE」 and share the website to your friend.